SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-000309
Filing Date
2022-01-04
Accepted
2022-01-04 17:14:45
Documents
15
Period of Report
2022-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20220103_8k.htm   iXBRL 8-K 29200
2 EXHIBIT 99.1 ex_321172.htm EX-99.1 42862
7 logo.jpg GRAPHIC 6207
  Complete submission text file 0001437749-22-000309.txt   238423

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20220104.xsd EX-101.SCH 4028
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20220104_def.xml EX-101.DEF 13400
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20220104_lab.xml EX-101.LAB 17561
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20220104_pre.xml EX-101.PRE 13371
9 EXTRACTED XBRL INSTANCE DOCUMENT govx20220103_8k_htm.xml XML 4275
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 22507396
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences